Extremity Medical Launches BioFuse Viable Cell Bone Graft

Extremity Medical launched BioFuse, a next-gen viable cell bone graft for use in the foot, ankle, wrist and hand. The product complements Extremity Medical's planned 2017 launches, such as the AXIS Charcot Fixation, KinematX Total Wrist Arthroplasty, MTP fusion and Jones fracture systems.

BioFuse comprises cells, biologic stimulants and a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us